160 related articles for article (PubMed ID: 16455310)
21. Vertebral and spinal cavernous angiomas associated with familial cerebral cavernous malformation.
Toldo I; Drigo P; Mammi I; Marini V; Carollo C
Surg Neurol; 2009 Feb; 71(2):167-71. PubMed ID: 18207546
[TBL] [Abstract][Full Text] [Related]
22. Cerebral cavernous malformation: new molecular and clinical insights.
Revencu N; Vikkula M
J Med Genet; 2006 Sep; 43(9):716-21. PubMed ID: 16571644
[TBL] [Abstract][Full Text] [Related]
23. A novel CCM1 gene mutation causes cerebral cavernous malformation in a Chinese family.
Zhao Y; Xie L; Li P; Song J; Qu T; Fan W; Chen H; Chen D; Lu D; Zhou L; Mao Y
J Clin Neurosci; 2011 Jan; 18(1):61-5. PubMed ID: 20884211
[TBL] [Abstract][Full Text] [Related]
24. Deep intronic KRIT1 mutation in a family with clinically silent multiple cerebral cavernous malformations.
Riant F; Odent S; Cecillon M; Pasquier L; de Baracé C; Carney MP; Tournier-Lasserve E
Clin Genet; 2014 Dec; 86(6):585-8. PubMed ID: 24251678
[TBL] [Abstract][Full Text] [Related]
25. Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas.
Laberge-le Couteulx S; Jung HH; Labauge P; Houtteville JP; Lescoat C; Cecillon M; Marechal E; Joutel A; Bach JF; Tournier-Lasserve E
Nat Genet; 1999 Oct; 23(2):189-93. PubMed ID: 10508515
[TBL] [Abstract][Full Text] [Related]
26. CCM3 mutations are uncommon in cerebral cavernous malformations.
Verlaan DJ; Roussel J; Laurent SB; Elger CE; Siegel AM; Rouleau GA
Neurology; 2005 Dec; 65(12):1982-3. PubMed ID: 16380626
[TBL] [Abstract][Full Text] [Related]
27. Surveying genetic variants and molecular phylogeny of cerebral cavernous malformation gene, CCM3/PDCD10.
Kumar A; Bhandari A; Goswami C
Biochem Biophys Res Commun; 2014 Dec; 455(1-2):98-106. PubMed ID: 25451273
[TBL] [Abstract][Full Text] [Related]
28. Interaction between krit1 and malcavernin: implications for the pathogenesis of cerebral cavernous malformations.
Zhang J; Rigamonti D; Dietz HC; Clatterbuck RE
Neurosurgery; 2007 Feb; 60(2):353-9; discussion 359. PubMed ID: 17290187
[TBL] [Abstract][Full Text] [Related]
29. CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis.
Zawistowski JS; Stalheim L; Uhlik MT; Abell AN; Ancrile BB; Johnson GL; Marchuk DA
Hum Mol Genet; 2005 Sep; 14(17):2521-31. PubMed ID: 16037064
[TBL] [Abstract][Full Text] [Related]
30. Impaired retinoic acid signaling in cerebral cavernous malformations.
Grdseloff N; Boulday G; Rödel CJ; Otten C; Vannier DR; Cardoso C; Faurobert E; Dogra D; Tournier-Lasserve E; Abdelilah-Seyfried S
Sci Rep; 2023 Apr; 13(1):5572. PubMed ID: 37019926
[TBL] [Abstract][Full Text] [Related]
31. Genetics of cerebral cavernous malformations.
Plummer NW; Zawistowski JS; Marchuk DA
Curr Neurol Neurosci Rep; 2005 Sep; 5(5):391-6. PubMed ID: 16131422
[TBL] [Abstract][Full Text] [Related]
32. A splice-site mutation in CCM1/KRIT1 is associated with retinal and cerebral cavernous hemangioma.
Kitzmann AS; Pulido JS; Ferber MJ; Highsmith WE; Babovic-Vuksanovic D
Ophthalmic Genet; 2006 Dec; 27(4):157-9. PubMed ID: 17148043
[TBL] [Abstract][Full Text] [Related]
33. Case Report: A novel heterozygous nonsense mutation in
Liu Z; Guo K; Hu X; Zhang X
Front Oncol; 2023; 13():1141488. PubMed ID: 37182185
[TBL] [Abstract][Full Text] [Related]
34. Comparative expression analysis of the MAGED genes during embryogenesis and brain development.
Bertrand M; Huijbers I; Chomez P; De Backer O
Dev Dyn; 2004 Jun; 230(2):325-34. PubMed ID: 15162511
[TBL] [Abstract][Full Text] [Related]
35. CCM2 and CCM3 proteins contribute to vasculogenesis and angiogenesis in human placenta.
Tanriover G; Seval Y; Sati L; Gunel M; Demir N
Histol Histopathol; 2009 Oct; 24(10):1287-94. PubMed ID: 19688696
[TBL] [Abstract][Full Text] [Related]
36. Expression of CCM2 and CCM3 during mouse gonadogenesis.
Yaba A; Ordueri NE; Tanriover G; Sahin P; Demir N; Celik-Ozenci C
J Assist Reprod Genet; 2015 Oct; 32(10):1497-507. PubMed ID: 26386873
[TBL] [Abstract][Full Text] [Related]
37. Presence of the brain proteins cerebral cavernous malformation-2 and cerebral cavernous malformation-3 in rat testes and their potential role in experimental varicocele.
Tanriover G; Sati L; Tekcan M; Demir N; Gunel M; Celik-Ozenci C
Fertil Steril; 2010 May; 93(8):2716-22. PubMed ID: 19647235
[TBL] [Abstract][Full Text] [Related]
38. ANKS1B Interacts with the Cerebral Cavernous Malformation Protein-1 and Controls Endothelial Permeability but Not Sprouting Angiogenesis.
Herberich SE; Klose R; Moll I; Yang WJ; Wüstehube-Lausch J; Fischer A
PLoS One; 2015; 10(12):e0145304. PubMed ID: 26698571
[TBL] [Abstract][Full Text] [Related]
39. Loss of p53 sensitizes mice with a mutation in Ccm1 (KRIT1) to development of cerebral vascular malformations.
Plummer NW; Gallione CJ; Srinivasan S; Zawistowski JS; Louis DN; Marchuk DA
Am J Pathol; 2004 Nov; 165(5):1509-18. PubMed ID: 15509522
[TBL] [Abstract][Full Text] [Related]
40. Krev1 interaction trapped-1/cerebral cavernous malformation-1 protein expression during early angiogenesis.
Guzeloglu-Kayisli O; Kayisli UA; Amankulor NM; Voorhees JR; Gokce O; DiLuna ML; Laurans MS; Luleci G; Gunel M
J Neurosurg; 2004 May; 100(5 Suppl Pediatrics):481-7. PubMed ID: 15287459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
